how big is Insecticid.India?

As of Jun 06, Insecticides India Ltd has a market capitalization of 2,491.84 Cr, classifying it as a Small Cap company, with recent net sales of 2000.40 Cr and net profit of 141.76 Cr.

Market Cap: As of Jun 06, Insecticides India Ltd has a market capitalization of 2,491.84 Cr, which classifies it as a Small Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, the sum of Net Sales is 2000.40 Cr, and the sum of Net Profit is 141.76 Cr. This data is Consolidated.<BR><BR>Balance Sheet Snapshot: This is Consolidated data for the latest annual period ending in Mar'24. Shareholder's Funds are reported at 1,013.53 Cr, and Total Assets amount to 1,713.50 Cr.

When is the next results date for Insecticid.India?

No Upcoming Board Meetings

Who are in the management team of Insecticid.India?

As of March 2022, the management team of Insecticid.India includes Hari Chand Aggarwal (Chairman), Rajesh Aggarwal (Managing Director), and several independent directors, along with whole-time directors and a compliance officer.

As of March 2022, the management team of Insecticid.India includes the following members:<BR><BR>1. Hari Chand Aggarwal - Chairman & Wholetime Director<BR>2. Rajesh Aggarwal - Managing Director<BR>3. NAVIN SHAH - Independent Director<BR>4. Virjesh Kumar Gupta - Independent Director<BR>5. Nikunj Aggarwal - Whole-time Director<BR>6. Jayaraman Swaminathan - Independent Director<BR>7. Sandeep Kumar - Company Secretary & Compliance Officer<BR>8. Parveen Gupta - Independent Director<BR>9. Anil Kumar Bhatia - Independent Director<BR>10. Anil Kurnar Goyal - Whole-time Director<BR><BR>The team comprises a mix of executive and independent directors, alongside a compliance officer.

What does Insecticid.India do?

Insecticides India Ltd is a small-cap company in the Pesticides & Agrochemicals industry, producing insecticides and agrochemical products. As of March 2025, it reported net sales of ₹359 Cr and a net profit of ₹14 Cr, with a market cap of ₹2,488 Cr.

Overview:<BR>Insecticides India Ltd is a small-cap company operating in the Pesticides & Agrochemicals industry, primarily engaged in the production of insecticides and agrochemical products.<BR><BR>History:<BR>Incorporated in 1996 as 'Insecticides (India) Private Limited', the company transitioned to a Public Limited Company and commenced commercial production in March 2002. The latest reported quarter for net sales and profit is March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 359 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 14 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: Rs 2,488 Cr (Small Cap)<BR><BR>Key Metrics:<BR>- P/E: 17.00<BR>- Industry P/E: 38<BR>- Dividend Yield: 0.24%<BR>- Debt-Equity: 0.04<BR>- Return on Equity: 13.07%<BR>- Price to Book: 2.29<BR><BR>Contact Details:<BR>Address: 401-402 Lusa Tower, Azadpur Commercial Complex Delhi Delhi : 110033<BR>Tel: 91-11-27671990-04<BR>Email: investor@insecticidesindia.com<BR>Website: http://www.insecticidesindia.com

What is the bonus history of the Insecticid.India?

Insecticides India Ltd has a history of issuing bonus shares, with the most recent being a 1:2 bonus announced on September 30, 2022, and a previous 1:2 bonus issued on April 17, 2015. This reflects the company's commitment to rewarding its shareholders.

Insecticides India Ltd has a history of bonus issues. The most recent bonus was a 1:2 issue, which was announced with an ex-date of September 30, 2022, and the record date was October 3, 2022. Prior to that, the company also issued a bonus in a 1:2 ratio on April 17, 2015, with an ex-date of April 16, 2015. This indicates that the company has consistently rewarded its shareholders with bonus shares in the past.

Has Insecticid.India declared dividend?

Insecticides India Ltd has declared a 20% dividend, amounting to ₹2 per share, with an ex-date of August 23, 2024. The company has shown strong total returns over various periods, particularly with a 218.19% total return over the last 5 years.

Insecticides India Ltd has declared a 20% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 20%<BR>- Amount per share: 2 per share<BR>- Ex-date: 23 Aug 24<BR><BR>Dividend Yield: 0.24%.<BR><BR>Total Returns by Period:<BR>In the 6-month period, the price return was 11.91%, with a dividend return of 0%, resulting in a total return of 11.91%.<BR><BR>For the 1-year period, the price return was 52.68%, the dividend return was 0.33%, leading to a total return of 53.01%.<BR><BR>Over the 2-year period, the price return was 86.94%, the dividend return was 1.11%, culminating in a total return of 88.05%.<BR><BR>In the 3-year period, the price return was 62.81%, with a dividend return of 2.07%, resulting in a total return of 64.88%.<BR><BR>For the 4-year period, the price return was 126.71%, the dividend return was 2.28%, leading to a total return of 128.99%.<BR><BR>In the 5-year period, the price return was 213.7%, with a dividend return of 4.49%, culminating in a total return of 218.19%.<BR><BR>Overall, Insecticides India Ltd has declared a dividend, contributing to a positive total return across various periods, particularly notable in the longer-term returns where price appreciation significantly outpaces dividend contributions.

Who are the peers of the Insecticid.India?

Peers of Insecticid.India include P I Industries, UPL, Bayer CropSci., and others. Insecticid.India has average management risk, below average growth, and the highest 1-year return at 65.72%.

Peers: The peers of Insecticid.India are P I Industries, UPL, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, India Pesticides, Meghmani Organi., Punjab Chemicals, Astec Lifescienc, and Heranba Inds.<BR><BR>Quality Snapshot: Excellent management risk is observed at Bayer CropSci., Dhanuka Agritech, and P I Industries, while Good management risk is found at Sumitomo Chemi. Average management risk is present at Insecticid.India, UPL, India Pesticides, Punjab Chemicals, and Heranba Inds. Below Average management risk is noted at Meghmani Organi. and Astec Lifescienc. For growth, Excellent growth is seen only at P I Industries, while Below Average growth is found at Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Insecticid.India, UPL, India Pesticides, Punjab Chemicals, and Heranba Inds, with Meghmani Organi. showing Below Average growth as well. Excellent capital structure is noted at P I Industries, Bayer CropSci., Sumitomo Chemi., Dhanuka Agritech, Insecticid.India, India Pesticides, and Punjab Chemicals, while Average capital structure is observed at Meghmani Organi. and Astec Lifescienc, and Below Average at UPL and Heranba Inds.<BR><BR>Return Snapshot: Insecticid.India has the highest 1-year return at 65.72%, while Astec Lifescienc has the lowest at -35.47%. Insecticid.India's return significantly outperforms Astec Lifescienc. Additionally, UPL, Meghmani Organi., Astec Lifescienc, and Heranba Inds have negative six-month returns.

Who are the top shareholders of the Insecticid.India?

The top shareholders of Insecticid.India include Rajesh Kumar Aggarwal with 16.63%, HDFC Small Cap Fund at 9.07%, and individual investors holding 10.43%. Foreign Institutional Investors collectively own 4.49%, with no pledged promoter holdings reported.

The top shareholders of Insecticid.India include the promoters, with Rajesh Kumar Aggarwal holding the highest individual stake at 16.63%. Additionally, mutual funds have a significant presence, with HDFC Small Cap Fund being the highest public shareholder at 9.07%. Foreign Institutional Investors (FIIs) collectively hold 4.49% through 45 different entities. Individual investors also have a notable share, accounting for 10.43% of the holdings. There are no pledged promoter holdings reported.

How has been the historical performance of Insecticid.India?

Insecticid.India has shown steady growth in net sales and profitability, with net sales increasing from 1,193.51 Cr in Mar'19 to 1,999.95 Cr in Mar'25, and profit after tax rising from 62.98 Cr to 141.45 Cr in the same period, despite rising operational costs. Total assets also grew to 1,898.15 Cr in Mar'25, indicating a positive overall financial trajectory.

Answer:<BR>The historical performance of Insecticid.India shows a steady growth in net sales and profitability over the years, with significant fluctuations in certain metrics.<BR><BR>Breakdown:<BR>Insecticid.India's net sales have increased from 1,193.51 Cr in Mar'19 to 1,999.95 Cr in Mar'25, reflecting a consistent upward trend. Total operating income followed a similar trajectory, reaching 1,999.95 Cr in Mar'25 from 1,801.33 Cr in Mar'23. However, total expenditure saw a rise to 1,778.74 Cr in Mar'25 from 1,679.44 Cr in Mar'23, indicating increased operational costs. The operating profit (PBDIT) has shown improvement, rising to 228.21 Cr in Mar'25 from 123.15 Cr in Mar'23, while profit before tax also increased to 192.20 Cr in Mar'25 from 83.60 Cr in Mar'23. Consequently, profit after tax reached 141.45 Cr in Mar'25, up from 62.98 Cr in Mar'23. The company's total assets grew to 1,898.15 Cr in Mar'25 from 1,696.31 Cr in Mar'23, while total liabilities increased to 1,898.15 Cr in Mar'25 from 1,719.22 Cr in Mar'24. Cash flow from operating activities improved significantly, resulting in a net cash inflow of 42.00 Cr in Mar'24, compared to a net outflow of 17.00 Cr in Mar'23. Overall, Insecticid.India has demonstrated a positive growth trajectory in sales and profits, despite some fluctuations in expenses and liabilities.

Are Insecticid.India latest results good or bad?

Insecticides India's latest results show mixed performance, with a slight net profit increase of 1.72% quarter-on-quarter but a 3.87% decline year-on-year. While there are some sequential improvements, the overall trends indicate more concerns than positives, suggesting operational stagnation.

The latest results for Insecticides India indicate a mixed performance. For the quarter ending September 2025, the company reported a net profit of ₹59.11 crore, which is a slight increase of 1.72% compared to the previous quarter. However, this represents a decline of 3.87% year-on-year, which raises concerns about profitability trends.<BR><BR>On the revenue side, net sales reached ₹637.70 crore, showing a modest year-on-year growth of 1.69%. This is significantly lower than the company's historical average sales growth of 7.55%. Additionally, there was a notable sequential decline of 7.73% from the previous quarter, reflecting typical seasonal patterns in the agrochemical sector but also highlighting potential challenges in maintaining market share.<BR><BR>The operating margin improved to 14.03%, up 179 basis points quarter-on-quarter, but this is down 25 basis points from the same quarter last year. The profit after tax margin also increased sequentially to 9.27%, yet it remains below the 9.81% achieved in the same quarter last year.<BR><BR>Overall, while there are some positive sequential improvements, the year-on-year declines in both net profit and operating metrics suggest underlying challenges that the company is facing. Therefore, the results can be characterized as more concerning than positive, indicating operational stagnation rather than robust growth.

Should I buy, sell or hold Insecticid.India?

Is Insecticid.India overvalued or undervalued?

As of November 13, 2025, Insecticid.India's valuation has shifted from very attractive to attractive, indicating it is undervalued with a PE ratio of 13.04, an EV to EBITDA of 9.20, and a PEG ratio of 0.85, especially when compared to peers like UPL and P I Industries, despite a recent 1-year return of -12.71% against the Sensex's 8.74%.

As of 13 November 2025, the valuation grade for Insecticid.India has moved from very attractive to attractive. Based on the analysis, the company appears to be undervalued. The key ratios indicate a PE ratio of 13.04, an EV to EBITDA of 9.20, and a PEG ratio of 0.85, all of which suggest a favorable valuation compared to its peers.<BR><BR>Insecticid.India's valuation can be compared to UPL, which has a PE ratio of 26.8, and P I Industries, which is considered very expensive with a PE of 35.84. These comparisons highlight that Insecticid.India is trading at a significantly lower valuation relative to its peers in the pesticides and agrochemicals industry. Despite recent underperformance against the Sensex, with a 1-year return of -12.71% compared to the Sensex's 8.74%, the company's fundamentals suggest it is positioned for potential growth.

Is Insecticid.India technically bullish or bearish?

As of December 2, 2025, the market trend has shifted to a bearish stance with moderate strength, indicated by bearish MACD, Bollinger Bands, moving averages, and KST on various time frames, alongside a lack of trend signals in Dow Theory and OBV.

As of 2 December 2025, the technical trend has changed from mildly bearish to bearish. The current stance is bearish with moderate strength. Key indicators driving this include a bearish MACD on the weekly chart, bearish Bollinger Bands on both weekly and monthly time frames, and bearish moving averages on the daily chart. The KST is also bearish on the weekly chart, contributing to the overall bearish sentiment. The lack of trend signals in the Dow Theory and OBV further supports the bearish outlook.

Which are the latest news on Insecticid.India?

Why is Insecticid.India falling/rising?

As of 04-Dec, Insecticides India Ltd's stock price is at 715.10, reflecting a slight decline and underperformance against its sector and benchmarks. The stock has shown negative returns over the past year and three years, with reduced investor interest and concerning growth metrics.

As of 04-Dec, Insecticides India Ltd's stock price is experiencing a slight decline, currently at 715.10, reflecting a change of -0.3 (-0.04%). The stock has been underperforming in the short term, having fallen consecutively for the last three days, resulting in a total drop of -1.47% during this period. Additionally, the stock's performance today has underperformed its sector by -0.87%.<BR><BR>In the context of broader market performance, the stock has shown a negative return of -5.00% over the past year, significantly lagging behind the Sensex, which has gained 5.32% in the same timeframe. This consistent underperformance is evident over the last three years, where the stock has generated negative returns compared to the benchmark.<BR><BR>Investor participation has also declined, with delivery volume dropping by -68.5% against the five-day average, indicating reduced interest in trading the stock. Although the company has a strong ability to service debt and is trading at a discount compared to its peers, the overall growth metrics are concerning. The net sales growth rate of 8.39% and operating profit growth of 14.44% over the last five years suggest poor long-term growth potential.<BR><BR>In summary, the combination of recent price declines, underperformance against benchmarks, falling investor participation, and lackluster growth prospects are contributing to the stock's current downward trend.